Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>Pinoresinol diglucoside (PDG), the active compound extracted from <em>Eucommia ulmoides</em>, <em>Styrax</em> sp. and <em>Forsythia suspensa</em>, plays the roles in regulating hypertension, inflammation and oxidative stress.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>Considering that hypertension and inflammation has been proved to contribute to cardiac remodeling, we tested the effects of PDG on cardiac hypertrophy (CM).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Male Sprague Dawley (SD) rats were used to construct hypertrophic rats by partial abdominal aortic constriction (AAC)-surgery. PDG solution (2 mg/ml) was used to treat AAC-induced rats by intraperitoneal injection at low dose (L-PDG, 2.5 mg/kg per day), medium dose (M-PDG, 5 mg/kg per day), and high dose (H-PDG, 7.5 mg/kg per day) for 3 weeks post AAC-surgery. CM was evaluated by the ratio of left ventricular weight to body weight ratio (LVW/BW), left ventricular wall thickness by H&E staining, and collagen content deposit by Masson's staining. Further, isoproterenol (ISO) and phenylephrine (PE) were used to produce cellular models of CM in neonatal rat ventricular cardiomyocytes (NRVMs). PDG pre-treated NRVMs 2 h at low dose (L-PDG, 2.5 μg/ml), medium dose (M-PDG, 5 μg/ml), and high dose (H-PDG, 7.5 μg/ml) for 24 h with or without PE- and ISO-stimulation. CM was evaluated by the expressions of hypertrophic biomarkers. Next, the hypertrophic biomarkers and pro-inflammatory cytokines were measured using quantitative real-time PCR (qRT-PCR), the expressions of protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/transcription factor nuclear factor-kappa B (NF-kB) signaling pathway were determined by Western blotting.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>PDG treatment prevented cardiac histomorphology damages, decreased upregulations of hypertrophic biomarkers, and prevented fibrosis and inflammation after pressure overload resulting from AAC-surgery. Consistently, PDG remarkably inhibited the changes of cardiomyocyte hypertrophic biomarkers and inflammatory responses in cellular models of CM. Interestingly, PDG administration inhibited the activation of AKT/mTOR/NF-kB signaling pathway both <em>in vivo</em> and <em>in vitro</em>.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>PDG prevents AAC-induced CM <em>in vivo</em>, PE- and ISO-induced CM <em>in vitro</em>. The AKT/mTOR/NF-kB signaling pathway could be the potential therapeutic target involved in the protection of PDG. These findings provide novel evidence that PDG might be a promising therapeutic strategy for CM.</p>

Polydatin modulates Ca2 + handling, excitation–contraction coupling and β-adrenergic signaling in rat ventricular myocytes

Cardioprotective effects of polydatin against myocardial injury in HFD/stz and high glucose-induced diabetes via a Caveolin 1-dependent mechanism

Polydatin modulates calcium signals in thermally injured cardiomyocytes

Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3

Polydatin improves vascular endothelial function by maintaining mitochondrial homeostasis under high glucose conditions

20(S)-Protopanaxadiol Alleviates Myocardial Ischemia/Reperfusion Injury In Rats Through Suppression Of Oxidative Stress And Apoptosis

Polydatin Restores Endothelium-Dependent Relaxation in Rat Aorta Rings Impaired by High Glucose: A Novel Insight into the PPARβ-NO Signaling Pathway.

Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats

Paeoniflorin Protects Diabetic Mice Against Myocardial Ischemic Injury Via the Transient Receptor Potential Vanilloid 1/calcitonin Gene-Related Peptide Pathway.

Polydatin Protects Against Hypoxia-induced Cardiomyocyte Injury by Inhibiting Cell Autophagy and PI3 K/AKT Pathway

Protective Effects of Polydatin on Multiple Organ Ischemia-Reperfusion Injury

Protective effects of PDTC on cardiomyopathy induced by adriamycin in rats and its mechanisms

The Effects of Puerarin on Rat Ventricular Myocytes and the Potential Mechanism

The role of polydatin in inhibiting oxidative stress through SIRT1 activation: A comprehensive review of molecular targets

Inhibition of NADPH Oxidase Mediates Protective Effect of Cardiotonic Pills against Rat Heart Ischemia/Reperfusion Injury.

The purified extract of steamed Panax ginseng protects cardiomyocyte from ischemic injury via caveolin-1 phosphorylation-mediating calcium influx

Polydatin Use in Vascular Dementia

Pigment Epithelium-Derived Factor (PEDF) Improves Ischemic Cardiac Functional Reserve Through Decreasing Hypoxic Cardiomyocyte Contractility Through PEDF Receptor (PEDF-R)

Polydatin prevents lipotoxicity-induced dysfunction in pancreatic -cells by inhibiting endoplasmic reticulum stress and excessive autophagy

Polydatin Modulates Inflammation By Decreasing Nf-Kappa B Activation And Oxidative Stress By Increasing Gli1, Ptch1, Sod1 Expression And Ameliorates Blood-Brain Barrier Permeability For Its Neuroprotective Effect In Pmcao Rat Brain

Calcium Dobesilate (CaD) Attenuates High Glucose and High Lipid-Induced Impairment of Sarcoplasmic Reticulum Calcium Handling in Cardiomyocytes